Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2016/05/006916
CTRI/2016/05/006916
Recruiting
Phase 2

Study of efficacy and safety of neo adjuvant chemotherapy in patients with Stage 2 B and 3 NSCLC: A pilot study

investigator initiated study0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: C349- Malignant neoplasm of unspecifiedpart of bronchus or lungHealth Condition 2: null- stage 2b and 3 Non Small Cell Lung Cancer

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: C349- Malignant neoplasm of unspecifiedpart of bronchus or lungHealth Condition 2: null- stage 2b and 3 Non Small Cell Lung Cancer
Sponsor
investigator initiated study
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
investigator initiated study

Eligibility Criteria

Inclusion Criteria

  • •1\.Pathological diagnosis of NSCLC
  • •2\.Age 18 to 75 years
  • •3\.ECOG PS 0\-2
  • •4\.Local disease T3 (with \> 5cm contact with chest wall) or T4
  • •5\.Mediastinal stage N0, N1 or non bulky N2 (defined as single station N2 station node \<2 cms in size or multiple matted nodes but \< 2cm at single N2 station) documented on PET scan and EBUS TBNA

Exclusion Criteria

  • •1\.ECOG PS \>2
  • •2\.Gross mediastinal structures invasion
  • •4\.Immunocompromised
  • •5\.Multiple comorbidities precluding possibilty of surgery
  • •6\.Poor PFT (predicted post operative FEV1 \< 800 cc not suitable for single lung anaesthesia)
  • •7\.Pregnent and lactating females

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Effect of preoperative chemotherapy in the treatment of patients with locally advanced rectal cancerRectal cancer.Malignant neoplasm of rectum
IRCT2016082129403N2Vice chancellor for research, Shiraz University of Medical Sciences40
Completed
Phase 2
Efficacy and safety of neoadjuvant chemotherapy by S-1 plus cisplatin for Stage III esophageal squamous cell carcinoma: A phase II trialEsophageal squamous cell carcinoma
JPRN-UMIN000014707agoya University Hospital30
Recruiting
N/A
A Study on the efficacy of neoadjuvant chemotherapy with carboplatin, docetaxel and bevacizumab in patients with non-squamous non-small cell lung canceron-Squamous Non-Small Cell Lung Cancer
JPRN-UMIN000008817ihon University School of Medicine Itabashi Hospital28
Completed
Phase 3
Investigating the effect of neoadjuvant chemotherapy on locally advanced rectal cancerocally advanced Rectal cancers.
IRCT20210308050628N1Hamedan University of Medical Sciences300
Completed
N/A
Prospective study of neoadjuvant chemotherapy for HER2 positive breast cancer.
JPRN-UMIN000046338Sapporo Medical University24